{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Roddy AC"],"funding":["Brainwaves Northern Ireland","Cancer Research UK studentship"],"pagination":["1219"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10135924"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["11(4)"],"pubmed_abstract":["Glioblastoma (GBM) is the most prevalent and aggressive adult brain tumor. Despite multi-modal therapies, GBM recurs, and patients have poor survival (~14 months). Resistance to therapy may originate from a subpopulation of tumor cells identified as glioma-stem cells (GSC), and new treatments are urgently needed to target these. The biology underpinning GBM recurrence was investigated using whole transcriptome profiling of patient-matched initial and recurrent GBM (recGBM). Differential expression analysis identified 147 significant probes. In total, 24 genes were validated using expression data from four public cohorts and the literature. Functional analyses revealed that transcriptional changes to recGBM were dominated by angiogenesis and immune-related processes. The role of MHC class I"],"journal":["Biomedicines"],"pubmed_title":["Transcriptional Profiling of a Patient-Matched Cohort of Glioblastoma (IDH-Wildtype) for Therapeutic Target and Repurposing Drug Identification."],"pmcid":["PMC10135924"],"funding_grant_id":["N/A","C11512/A20877","NIC103464"],"pubmed_authors":["Salto-Tellez M","Spence VJ","Stewart JP","Roddy AC","Flannery T","Healy EG","McInerney CE","Walsh J","McArt DG","Prise KM"],"additional_accession":[]},"is_claimable":false,"name":"Transcriptional Profiling of a Patient-Matched Cohort of Glioblastoma (IDH-Wildtype) for Therapeutic Target and Repurposing Drug Identification.","description":"Glioblastoma (GBM) is the most prevalent and aggressive adult brain tumor. Despite multi-modal therapies, GBM recurs, and patients have poor survival (~14 months). Resistance to therapy may originate from a subpopulation of tumor cells identified as glioma-stem cells (GSC), and new treatments are urgently needed to target these. The biology underpinning GBM recurrence was investigated using whole transcriptome profiling of patient-matched initial and recurrent GBM (recGBM). Differential expression analysis identified 147 significant probes. In total, 24 genes were validated using expression data from four public cohorts and the literature. Functional analyses revealed that transcriptional changes to recGBM were dominated by angiogenesis and immune-related processes. The role of MHC class I","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Apr","modification":"2026-04-08T12:39:20.493Z","creation":"2025-04-05T19:41:02.035Z"},"accession":"S-EPMC10135924","cross_references":{"pubmed":["37189838"],"doi":["10.3390/biomedicines11041219"]}}